Paper Details

  1. Home
  2. Paper Details

Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.

Author: DahlöfC, FärkkiläM, MuirheadN, OlesenJ, RasmussenS, SikesC, StovnerL J, ter BruggenJ P

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study evaluated the tolerability and efficacy of eletriptan in patients who had discontinued oral sumatriptan due to lack of efficacy or intolerable adverse events. Eletriptan was effective and well tolerated in these patients.
Paper Details　
Original Abstract of the Article :
To determine the tolerability and efficacy of eletriptan in patients who had discontinued oral sumatriptan due to lack of efficacy or intolerable adverse events (AEs) during previous clinical treatment (not a controlled trial). Eletriptan is a potent, selective 5-HT1B/1D receptor agonist with benefi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1468-2982.2003.00554.x

データ提供：米国国立医学図書館（NLM）

Eletriptan: A New Path for Migraine Relief

[Migraine headaches] are a debilitating condition that can make life feel like a desert mirage. This study focused on [eletriptan], a medication for treating [migraine headaches], and its potential to provide relief for patients who had previously struggled with [oral sumatriptan]. It's like finding a new oasis after a long, arduous journey – a fresh start with the promise of relief. The researchers compared [eletriptan] to [placebo] in a [double-blind, parallel group, placebo-controlled multicentre study] to evaluate its [tolerability and efficacy].

Eletriptan: A Promising Alternative

[Eletriptan] demonstrated significant improvement in [headache response] compared to [placebo], suggesting that it can be an effective option for patients who haven't found relief with [oral sumatriptan]. It's like discovering a hidden spring in the desert – a source of unexpected relief.

Managing Migraine Headaches

This study highlights the importance of exploring different treatment options for [migraine headaches]. It's like having a variety of tools for navigating the desert – different approaches can work better for different individuals. Understanding the potential benefits and risks of [eletriptan] can help patients make informed decisions about their treatment options.

Dr.Camel's Conclusion

The struggle with [migraine headaches] can feel like an endless journey through a desert. This study offers hope for patients who haven't found relief with traditional treatments. Eletriptan represents a potential new oasis, offering a chance for a brighter future.

Date :
  1. Date Completed 2004-01-20
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

12807526

DOI: Digital Object Identifier

10.1046/j.1468-2982.2003.00554.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.